SCHEMBL4909330

SCHEMBL4909330

COC(=O)c1ccc(Oc2ncc(Cl)cc2N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
LMNA P02545 3/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
APEX1 P27695 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PTGER4 P35408 4/20 0.46
MAPK1 P28482 1/20 0.46
ABL1 P00519 1/20 0.44
MAPT P10636 3/20 0.44
LIPE Q05469 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
BCHE P06276 1/20 0.44
PTGER2 P43116 2/20 0.43
CCR2 P41597 1/20 0.43
USP2 O75604 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911339 0.86 L3MBTL1 (0.54) PTGER4ABL1PTGER2CCR2USP2
SCHEMBL30230598 0.85 TDP1 (0.46) ALDH1A1LMNATSHRSMN1; SMN2PTGER4
SCHEMBL4911314 0.85 CCR2 (0.44) ALDH1A1PTGER4ABL1CCR2USP2
SCHEMBL29254725 0.84 PTGER4 (0.48) ALDH1A1LMNACYP2C9TSHRAPEX1
SCHEMBL10474178 0.80 L3MBTL1 (0.57) ALDH1A1LMNACYP2C9TSHRAPEX1
SCHEMBL4913347 0.80 MAPT (0.56) ALDH1A1LMNACYP2C9TSHRAPEX1
SCHEMBL10499451 0.79 MAPK1 (0.71) ALDH1A1LMNACYP2C9TSHRAPEX1
SCHEMBL14513363 0.78 SMN1; SMN2 (0.61) ALDH1A1LMNACYP2C9TSHRAPEX1
SCHEMBL4912893 0.78 ALDH1A1 (0.51) ALDH1A1LMNACYP2C9SMN1; SMN2PTGER4
SCHEMBL2152852 0.77 ALDH1A1 (0.46) ALDH1A1LMNATSHRSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 ALDH1A1 1334/4885LMNA 4659/4885CYP2C9 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.